All the news

A hepatitis B immunuglobulin-free strategy for prevention of mother-to-child hepatitis B transmission is feasible and highly effective in a resource-limited setting if tenofovir is given for at least four weeks prior to delivery, ...

Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ...

Almost 7% of healthcare workers in Africa have hepatitis B and 5% have hepatitis C, according to a systematic review of published studies. Greater efforts to vaccinate against hepatitis B and improve ...

Screening for sexually transmitted infections in people co-infected with HIV and hepatitis C during or shortly after completing direct-acting antiviral treatment to cure hepatitis C may predict which patients are at higher risk ...

Hepatitis C is becoming more concentrated in gay and bisexual men with HIV in France as direct-acting antiviral treatment cures the infection in other people with HIV while hepatitis C transmission between ...

Tenofovir alafenamide (TAF; Vemlidy) is highly effective at preventing transmission of hepatitis B virus (HBV) from mothers with a high viral load to their infants, according to a pair of studies presented ...

Pregnant women who test positive for hepatitis B infection and have a high level of hepatitis B virus (HBV) in the blood should receive preventive antiviral therapy with tenofovir from the 28th week ...